|
Synonyms: capromab pendetide | CYT-351 | CYT-356 | Indium In 111 capromab | ProstaScint®
capromab is an approved drug (FDA (1996))
Compound class:
Antibody
Comment: Used as an imaging agent (ProstaScint) by labelling with the radionuclide Indium-111 (using capromab pendetide, where the pendetide is the chelating agent for the radiolabel).
|
Classification  |
|
| Compound class | Antibody |
| Approved drug? | Yes (FDA (1996)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 7201 | capromab |
| Synonyms |
| capromab pendetide | CYT-351 | CYT-356 | Indium In 111 capromab | ProstaScint® |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 115 |
| Other databases | |
| GtoPdb PubChem SID | 178103460 |
| PubChem SID | 178103460 |
| Search PubMed clinical trials | capromab |
| Search PubMed titles | capromab |
| Search PubMed titles/abstracts | capromab |
| Wikipedia | Indium (111In) capromab pendetide |
